Impact of Killing in War: A Randomized, Controlled Pilot Trial
Objective The purpose of this pilot study was to test the effectiveness of Impact of Killing (IOK), a novel, cognitive‐behavioral treatment (CBT) aimed at reducing mental health symptoms and functional impairment. Method Participants were 33 combat Veterans with a posttraumatic stress disorder (PTSD...
Saved in:
Published in | Journal of clinical psychology Vol. 73; no. 9; pp. 997 - 1012 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Periodicals Inc
01.09.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Objective
The purpose of this pilot study was to test the effectiveness of Impact of Killing (IOK), a novel, cognitive‐behavioral treatment (CBT) aimed at reducing mental health symptoms and functional impairment.
Method
Participants were 33 combat Veterans with a posttraumatic stress disorder (PTSD) diagnosis who had completed trauma‐focused psychotherapy and reported distress regarding killing or feeling responsible for the deaths of others in war. Veterans were randomized to either IOK treatment or a 6‐week waitlist condition, after which Veterans could receive IOK. IOK is a 6‐ to 8‐session, weekly, individual, CBT, lasting 60–90 minutes, and focused on key themes, including physiology of killing responses, moral injury, self‐forgiveness, spirituality, making amends, and improved functioning.
Results
We found that compared to controls (N = 16), the IOK group (N = 17) experienced a significant improvement in PTSD symptoms, general psychiatric symptoms, and quality of life functional measures. Veterans who received IOK reported that the treatment was acceptable and feasible.
Conclusion
These results provide preliminary evidence that Veterans can benefit from a treatment focused on the impact of killing after initial trauma therapy. |
---|---|
Bibliography: | This research was funded by VA Health Services Research and Development RRP 12–237 (PI: Maguen); University of California, San Francisco REAC 525014–36248 (PI: Maguen); and VA Health Sciences Research and Development Research Career Development Award 06–042 (PI: Maguen). The funding sources did not play a role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. We thank all of the veterans who participated in this research and shared their stories and experiences with us. We also thank Rosemary Griffin, MPH, Peter Yeomans, PhD, the VHA PTSD clinicians, and the many others who provided referrals and feedback, without whom this work would not be possible. ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-News-1 ObjectType-Feature-3 content type line 23 |
ISSN: | 0021-9762 1097-4679 |
DOI: | 10.1002/jclp.22471 |